Assessing osteonecrosis of the femoral head after internal fixation of femoral neck fractures: MARS MRI versus conventional radiography and patient-reported outcomes

Research output: Contribution to journalJournal articleResearchpeer-review

Documents

  • Fulltext

    Final published version, 658 KB, PDF document

  • Mikael Kindt
  • Maria L. Jönsson
  • Trine Torfing
  • Sebastian Strøm Rönnquist
  • Bjarke Viberg
  • Overgaard, Søren
  • Cecilia Rogmark

Background and purpose — Little is known on the use of metal artifact reduction sequence (MARS) MRI to diagnose osteonecrosis of the femoral head (ONFH) after fixation of femoral neck fractures (FNF) with conventional metal implants present. We compared MARS MRI with radiography in diagnosing ONFH. Secondarily, we determined whether signs of ONFH on MARS MRI correlate with patient-reported outcomes (PROs) via Oxford Hip Score (OHS) and pain (VAS). Patients and methods — 30 adults under 60 years treated with internal fixation after FNF were prospectively included (2015–2018) at 2 hospitals. They were followed up with radiography and PROs at 4, 12, and 24 months and MARS MRI at 4 and 12 months. OHS < 34 or VAS pain > 20 was considered significant. Results — At 12 months, 14 patients had a pathological MRI. 3 of 14 had ONFH on radiographs at 12 months, increasing to 5 at 24 months, and 4 had unfavorable PROs. 2 of 5 patients with ONFH signs on both MRI and radiography had unfavorable PROs. 1 of 10 patients with normal MRI and radiography had unfavorable 2-year PROs. 4 patients had inconsistent MRI results, of which 1 developed ONFH. 1 patient dropped out. Conclusion — Information from a pathological MRI was not useful, as a majority remained free from symptoms and ONFH signs on radiographs. Furthermore, PROs did not correlate with imaging results. MARS MRI findings must be better understood before being taken into clinical practice. However, a normal MARS MRI seems to be a good prog-nostic finding.

Original languageEnglish
JournalActa Orthopaedica
Volume94
Pages (from-to)135-140
Number of pages6
ISSN1745-3674
DOIs
Publication statusPublished - 2023

Bibliographical note

Funding Information:
HFU-60 was approved by ethical review boards in Sweden (Regionala etikprövningsnämnden Lund, Dnr: 2015/28) and Denmark (Videnskabsetisk Komité for Region Syddan-mark, projekt ID: s-20150137), registered at ClinicalTrials. gov (NCT03848195), and conducted in accordance with the Helsinki declaration. All participating patients gave their written informed consent. Data may be shared upon reasonable request. The HFU-60 project was supported by grants from the Greta and Johan Kock Foundation, A. Påhlsson Foundation, H. Järnhardt foundation, Skåne University Hospital Research Fund, the Research and Development Council of Region Skåne, the Swedish Research Council funding for clinical research in medicine, and “Region Syddanmarks for-skningsfond” from the Region of Southern Denmark. None of the funders had influence on the scientific work of this study. None of the authors have any financial or competing interests. Completed disclosure forms for this article following the ICMJE template are available on the article page, doi: 10.2340/17453674.2023.11658

Publisher Copyright:
© 2023 The Author(s).

ID: 367350280